Biomarkers of the Dementia
Author
Source
International Journal of Alzheimer's Disease
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-05-30
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Recent advances in biomarker studies on dementia are summarized here.
CSF Aβ40, Aβ42, total tau, and phosphorylated tau are the most sensitive biomarkers for diagnosis of Alzheimer's disease (AD) and prediction of onset of AD from mild cognitive impairment (MCI).
Based on this progress, new diagnostic criteria for AD, MCI, and preclinical AD were proposed by National Institute of Aging (NIA) and Alzheimer's Association in August 2010.
In these new criteria, progress in biomarker identification and amyloid imaging studies in the past 10 years have added critical information.
Huge contributions of basic and clinical studies have established clinical evidence supporting these markers.
Based on this progress, essential therapy for cure of AD is urgently expected.
American Psychological Association (APA)
Shoji, Mikio. 2011. Biomarkers of the Dementia. International Journal of Alzheimer's Disease،Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-481124
Modern Language Association (MLA)
Shoji, Mikio. Biomarkers of the Dementia. International Journal of Alzheimer's Disease No. 2011 (2011), pp.1-7.
https://search.emarefa.net/detail/BIM-481124
American Medical Association (AMA)
Shoji, Mikio. Biomarkers of the Dementia. International Journal of Alzheimer's Disease. 2011. Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-481124
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-481124
